Navigation Links
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2008 Financial Results Conference Call
Date:7/1/2008

PRINCETON, N.J., July 1 /PRNewswire-FirstCall/ -- In conjunction with its second quarter 2008 earnings release (expected to be issued after market close on July 30), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, July 31, 2008 at 9:00 a.m. ET.

What: Covance Second Quarter 2008 Earnings Webcast and Slide

Presentation

When: July 31, 2008, 9:00 a.m. ET*

Where: http://www.covance.com

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.

*If you are unable to participate during the live webcast, the event will be archived on the web site http://www.covance.com for 14 days.


'/>"/>
SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Covance to Present at the William Blair Growth Stock Conference
2. Covance Elects Joseph C. Scodari to Companys Board of Directors
3. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call
4. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
5. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
6. Covance to Present at UBS Global Healthcare Services Conference
7. Covance to Present at 26th Annual JPMorgan Healthcare Conference
8. Wendel Barr Appointed Chief Operating Officer of Covance
9. Covance and Care Partner on Rwanda Early Childhood Development Initiative
10. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
11. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: